Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Gozzetti

Showing results (71-80 of 212) with videos related to

Pageof 22
Sort By:
Leukemia & Lymphoma|November 3, 2005
Low-dose thalidomide-induced agranulocytosis in a multiple myeloma patient treated at diagnosisSerena Mazzotta, Alessandro Gozzetti, Maria Teresa Pirrotta, et al.
Acta Haematologica|March 29, 2007
Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patientsMaria Teresa Pirrotta, Monica Bocchia, Alessandro Bucalossi, et al.
Acta Haematologica|February 20, 2007
Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatmentAlessandro Gozzetti, Monica Bocchia, Simona Calabrese, et al.
Leukemia Research|March 15, 2011
Unusual localizations of plasmacytomaAlessandro Gozzetti, Giuseppe Coviello, Alberto Fabbri, et al.
Cancer Research|October 3, 2002
Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomasAlessandro Gozzetti, Elizabeth M Davis, Rafael Espinosa, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Drug resistance and minimal residual disease in multiple myelomaAlessandro Gozzetti, Sara Ciofini, Anna Sicuranza, et al.
Cancer Genetics and Cytogenetics|August 19, 2007
Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemiaAlessandro Gozzetti, Simona Calabrese, Donatella Raspadori, et al.
British Journal of Haematology|September 15, 2007
Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphomaAlberto Fabbri, Mariapia Lenoci, Alessandro Gozzetti, et al.
Cancer Drug Resistance (Alhambra, Calif.)|April 17, 2023
Anti-BCMA novel therapies for multiple myelomaVincenzo Sammartano, Marta Franceschini, Sara Fredducci, et al.
Acta Haematologica|July 8, 2010
A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2Alessandro Gozzetti, Rosaria Crupi, Michela Rondoni, et al.
Pageof 22

Showing results (71-80 of 212) with videos related to

Sort By:
Pageof 22
Leukemia & Lymphoma|November 3, 2005
Low-dose thalidomide-induced agranulocytosis in a multiple myeloma patient treated at diagnosisSerena Mazzotta, Alessandro Gozzetti, Maria Teresa Pirrotta, et al.
Acta Haematologica|March 29, 2007
Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patientsMaria Teresa Pirrotta, Monica Bocchia, Alessandro Bucalossi, et al.
Acta Haematologica|February 20, 2007
Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatmentAlessandro Gozzetti, Monica Bocchia, Simona Calabrese, et al.
Leukemia Research|March 15, 2011
Unusual localizations of plasmacytomaAlessandro Gozzetti, Giuseppe Coviello, Alberto Fabbri, et al.
Cancer Research|October 3, 2002
Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomasAlessandro Gozzetti, Elizabeth M Davis, Rafael Espinosa, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Drug resistance and minimal residual disease in multiple myelomaAlessandro Gozzetti, Sara Ciofini, Anna Sicuranza, et al.
Cancer Genetics and Cytogenetics|August 19, 2007
Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemiaAlessandro Gozzetti, Simona Calabrese, Donatella Raspadori, et al.
British Journal of Haematology|September 15, 2007
Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphomaAlberto Fabbri, Mariapia Lenoci, Alessandro Gozzetti, et al.
Cancer Drug Resistance (Alhambra, Calif.)|April 17, 2023
Anti-BCMA novel therapies for multiple myelomaVincenzo Sammartano, Marta Franceschini, Sara Fredducci, et al.
Acta Haematologica|July 8, 2010
A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2Alessandro Gozzetti, Rosaria Crupi, Michela Rondoni, et al.
Pageof 22